Literature DB >> 26239136

miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.

Ran Xu1, Guang Zeng2, Jing Gao3, Yue Ren1, Zhe Zhang1, Qingna Zhang1, Jinxiu Zhao1, Hong Tao1, Daxu Li1.   

Abstract

Aberrant microRNA expression has been suggested to be an important event in the pathologies of various types of cancer. MicroRNA-138 (miR-138) has been reported to be frequently downregulated in various types of human cancer, including oral squamous cell carcinoma (OSCC). However, the precise molecular mechanism of miR-138 underlying OSCC remains largely unknown. The aim of the present study was to investigate the expression of miR-138 in OSCC tumor tissues and several OSCC cell lines and validated its interaction with the 3'-untranslated region (3'-UTR) of Yes-associated protein 1 (YAP1). The results showed that, miR-138 was significantly downregulated in OSCC tumor tissues and cell lines. Overexpression of miR-138 inhibited cell proliferation of OSCC cells whereas the downregulation of miR-138 promoted cell proliferation. A direct interaction between miR-138 and 3'-UTR of YAP1 was validated by dual-luciferase reporter assay. Moreover, overexpression of miR-138 in OSCC cells significantly decreased the expression of YAP1 and downregulation of miR-138 inhibited the expression of YAP1. Specifically, the inhibitory effect of miR-138 on the proliferation of OSCC cells was eliminated by transfection with YAP1 overexpression vectors that did not harbor any specific miR-138 binding specific sequences in 3'-UTR. In addition, the miR-138‑overexpressing OSCC cells exhibited a low growth rate in the xenograft tumor assay with a decreased expression of YAP1 in tumor tissues. The results suggest that miR-138 is a tumor suppressor miRNA in OSCC through targeting YAP1, which serves as a promising therapeutic target for the treatment of OSCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239136     DOI: 10.3892/or.2015.4144

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  MicroRNA-138 targets SP1 to inhibit the proliferation, migration and invasion of hepatocellular carcinoma cells.

Authors:  Chongzhong Liu; Jiankang Zhu; Fengyue Liu; Yadong Wang; Min Zhu
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

2.  MicroRNA-138 suppresses cell proliferation and invasion of renal cell carcinoma by directly targeting SOX9.

Authors:  Bo Hu; Jianbo Wang; Xunbo Jin
Journal:  Oncol Lett       Date:  2017-10-10       Impact factor: 2.967

3.  Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules.

Authors:  Yayi He; Yang Yang; Peng Kuang; Shengxiang Ren; Leslie Rozeboom; Christopher J Rivard; Xuefei Li; Caicun Zhou; Fred R Hirsch
Journal:  Onco Targets Ther       Date:  2017-12-13       Impact factor: 4.147

4.  Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.

Authors:  Priscila Campioni Rodrigues; Iris Sawazaki-Calone; Carine Ervolino de Oliveira; Carolina Carneiro Soares Macedo; Mauricio Rocha Dourado; Nilva K Cervigne; Marcia Costa Miguel; Andreia Ferreira do Carmo; Daniel W Lambert; Edgard Graner; Sabrina Daniela da Silva; Moulay A Alaoui-Jamali; Adriana Franco Paes Leme; Tuula A Salo; Ricardo D Coletta
Journal:  Oncotarget       Date:  2017-08-19

5.  Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1.

Authors:  Zhenchao Yuan; Hao Mo; Ligen Mo; Juliang He; Zhenjie Wu; Xiang Lin
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

6.  MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma.

Authors:  Zheng Zhou; Zhihong Li; Yi Shen; Tao Chen
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

7.  MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.

Authors:  Ling Xiao; Hui Zhou; Xiang-Ping Li; Juan Chen; Chao Fang; Chen-Xue Mao; Jia-Jia Cui; Wei Zhang; Hong-Hao Zhou; Ji-Ye Yin; Zhao-Qian Liu
Journal:  Oncotarget       Date:  2016-06-28

8.  MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.

Authors:  Fengzhi Si; Jie Sun; Chunli Wang
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

9.  Long non-coding RNA NEAT1 promotes migration and invasion of oral squamous cell carcinoma cells by sponging microRNA-365.

Authors:  Xiaohua Liu; Wenzhi Shang; Fuju Zheng
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

10.  miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma.

Authors:  Yahui Liu; Wei Zhang; Kai Liu; Songyang Liu; Bai Ji; Yingchao Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.